The survivorship experience of young adults, as well as adolescents and children, who have had #bloodcancer varies widely, necessitating carefully tailored interventions to meet their specific needs. Published in Supportive Care in Cancer: Springer Journal. bit.ly/4lF3RQL #AYACancer

The discharge of pediatric patients after HSCT is a complex and often tenuous process, but a multidisciplinary approach can better prepare patients and their caregivers for the transition from hospital to home. Reported in Nursing Reports MDPI. bit.ly/3UoOZKd #hemonc

Children with CNS NGGCTs may have better #IQrecovery if they receive proton radiotherapy rather than photon radiotherapy. Presented at ASCO conference #ASCO2025, covered by CancerTherapyAdvisor. bit.ly/3TU7Soi

Adolescents and young adults face wide-ranging challenges after blood cancer, especially financial ones. A study co-authored by #TuftsMedicine's Susan Parsons, MD, explores tailored support for survivors. Featured in OncologyNurseAdvisor: bit.ly/4lF3RQL #AYAcancer #Survivorship

Sociodemographic disparities affect the uptake of the 2021 United States Preventive Services Task Force’s recommendation to begin #colorectalCancer screening at age 45 years. Published in DCRjournal and Gastroenterology Advisor. bit.ly/4maIvKZ #crcsm

Early dynamic variation in the neutrophil-to-lymphocyte ratio during IMRT accurately predicted radiation-induced hepatic toxicity in patients with #hepatocellularCarcinoma. Published in Rare Disease Advisor. bit.ly/4lFXeNY #HCC

Early oncologic outcomes after RP for very high risk #prostatecancer appear better when patients are staged using PSMA-PET rather than conventional imaging. Presented at #AUA2025. bit.ly/44WRzMq #pcsm

In a study of more than 6 million #cancersurvivors, about 1 in 12 reported using #cannabis, and nearly half of them said they used cannabis for medical reasons. Published in JCO Oncology Practice and CancerTherapyAdvisor. bit.ly/4f2Lbrr

Researchers developed a new risk prediction model for methotrexate-related neurotoxicity in young patients being treated for acute #lymphoblasticLeukemia. Reported in The Oncologist. bit.ly/4fk04Gg #leusm

ICI therapy was associated with a greater frequency of certain MACEs, such as myocarditis and pericarditis, in patients with primary #lungcancer identified in a nationwide database in Japan. Reported in The Oncologist. bit.ly/4o82trz #lcsm

Hereditary breast and #ovariancancer genetic testing uptake were low among underserved women being screened for #breastcancer. Published in The Oncologist. bit.ly/4l12bQf #gyncsm #bcsm

Sacituzumab govitecan plus pembrolizumab improves outcomes when compared to chemotherapy plus pembrolizumab in patients with previously untreated, PD-L1-positive advanced triple-negative #breastcancer. Presented at #ASCO2025, covered by CancerTherapyAdvisor. bit.ly/3TXI8Y9

The United States FDA has approved the use of Sirtex Medical’s Y-90 resin microspheres (SIR-Spheres®) to treat unresectable #hepatocellularCarcinoma. From Rare Disease Advisor. bit.ly/4lU3stO #HCC

Having detectable ctDNA before treatment is associated with worse outcomes among patients with #mCRPC, regardless of the treatment they receive. Published in European Urology Oncology. bit.ly/4fawqD7 #pcsm #prostatecancer

Phase 2 trial results support Isa-KRd as a standard treatment option for patients with high-risk, newly diagnosed #multipleMyeloma. Presented at #EHA2025, covered by CancerTherapyAdvisor. bit.ly/3UDAQsA

Oral complications were common among patients with head and neck cancer who undergo radiotherapy or chemoradiation. Published in Scientific Reports. bit.ly/3Jg6pGu #hncsm

An online pediatric communication skill training increased confidence and communication skills among registered #nurses. Published in Psycho-Oncology. bit.ly/4m3y3W1 #OncNurse

Patient processing speed is a critical indicator of cognitive function in #cancercare and deserves close monitoring and the initiation of appropriate interventions. Published in Seminars in Oncology Nursing. bit.ly/4m2KmBE

Recent increases in #HCC-related mortality rates in the United States have been greater among rural residents than urban ones, as have hepatitis C-related HCC mortality rates. Published in AJG - The American Journal of Gastroenterology and Gastroenterology Advisor. bit.ly/45eUTEd

Adding polatuzumab vedotin to treatment with R-GemOx can improve survival outcomes in patients with R/R #DLBCL. Presented at #EHA2025, from CancerTherapyAdvisor. bit.ly/46Er7d1 #lymphoma